Skip to content
Wenlo
Sign in
← Markets
Market closed · Opens Mon 4:00 AM ET

NPCE NeuroPace, Inc.

NASDAQ
$7.97−$0.17 (−2.09%)

As of 3:59 PM ET

  • NPCE

Loading chart…

Open
$8.14
Previous close
$8.14
Day range
7.84 – 8.28
52-week range
5.46 – 19.60
Volume
50.5K
Avg volume (3M)
262.1K
Market cap
$282.5M
P/E (TTM)
−12.45
EPS (TTM)
−$0.56
Beta
1.93
Dividend yield
0.00%
Next earnings
Feb 11, 2027(estimated from past report dates; not yet confirmed by the company)
Ex-dividend
—
Sector
Healthcare

About NeuroPace, Inc.

NeuroPace, Inc. is a medical device company focused on brain-responsive neuromodulation for people living with epilepsy. Its core RNS System is an implantable platform designed to detect abnormal brain activity and deliver targeted stimulation in response, helping physicians manage medically refractory focal epilepsy. The company’s product portfolio includes the RNS neurostimulator, depth and cortical strip leads, and accompanying patient monitoring and programming tools that support long-term therapy and remote clinical review. NeuroPace serves hospitals and epilepsy care centers, with its technology used in specialized neurology settings where individualized treatment is critical. The company operates in the neuromodulation and epilepsy treatment markets, where it plays a distinct role by combining continuous brain signal monitoring with responsive therapy in a single commercial system.

NPCE news and filings

Loading filings…

Filings from SEC EDGAR.